|
|
Exchange: |
Over The Counter |
Security
Type: |
N/A |
Shares
Out: |
19,300,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$57.98 - $57.98 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Larose Jeffrey |
Chief Scientific Officer |
|
2014-04-01 |
4 |
OE |
$16.18 |
$61,590 |
D/D |
2,179 |
3,001 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2014-03-31 |
4 |
AS |
$91.05 |
$158,970 |
D/D |
(1,744) |
7,719 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2014-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
9,463 |
|
- |
|
Hathaway David R |
Chief Medical Officer |
|
2014-03-11 |
4 |
S |
$95.00 |
$267,140 |
D/D |
(2,812) |
0 |
|
- |
|
Hathaway David R |
Chief Medical Officer |
|
2014-03-11 |
4 |
OE |
$18.02 |
$50,672 |
D/D |
2,812 |
2,812 |
|
- |
|
Mcaree Peter F |
SVP, CFO and Treasurer |
|
2014-03-11 |
4 |
AS |
$93.71 |
$43,575 |
D/D |
(465) |
4,921 |
|
- |
|
Hathaway David R |
Chief Medical Officer |
|
2014-03-10 |
4 |
S |
$95.00 |
$152,095 |
D/D |
(1,601) |
0 |
|
- |
|
Hathaway David R |
Chief Medical Officer |
|
2014-03-10 |
4 |
OE |
$18.08 |
$5,406 |
D/D |
299 |
1,601 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2014-03-10 |
4 |
S |
$93.56 |
$469,484 |
D/D |
(5,018) |
822 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-03-10 |
4 |
S |
$94.22 |
$188,440 |
D/D |
(2,000) |
7,769 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-03-10 |
4 |
OE |
$23.79 |
$47,580 |
D/D |
2,000 |
9,769 |
|
- |
|
Mcaree Peter F |
SVP, CFO and Treasurer |
|
2014-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
5,386 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2014-03-03 |
4 |
AS |
$92.95 |
$202,975 |
D/D |
(2,179) |
5,840 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2014-03-03 |
4 |
OE |
$15.61 |
$34,014 |
D/D |
2,179 |
8,019 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2014-02-10 |
4 |
AS |
$94.61 |
$67,552 |
D/D |
(714) |
4,213 |
|
- |
|
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2014-02-10 |
4 |
AS |
$94.57 |
$229,616 |
D/D |
(2,428) |
56,126 |
|
- |
|
Yocher Robert E |
SVP, Regulatory & Quality |
|
2014-02-10 |
4 |
AS |
$94.57 |
$40,476 |
D/D |
(428) |
4,242 |
|
- |
|
Mcaree Peter F |
SVP, CFO and Treasurer |
|
2014-02-10 |
4 |
AS |
$94.62 |
$67,559 |
D/D |
(714) |
3,986 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-02-10 |
4 |
AS |
$94.72 |
$76,723 |
D/D |
(810) |
7,769 |
|
- |
|
Larose Jeffrey |
Chief Scientific Officer |
|
2014-02-10 |
4 |
AS |
$94.58 |
$64,787 |
D/D |
(685) |
5,840 |
|
- |
|
Knopf Lawrence J |
General Counsel |
|
2014-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
4,927 |
|
- |
|
Godshall Douglas Evan |
President & Chief Exec Officer |
|
2014-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
58,554 |
|
- |
|
Yocher Robert E |
SVP, Regulatory & Quality |
|
2014-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
800 |
4,670 |
|
- |
|
Mcaree Peter F |
SVP, CFO and Treasurer |
|
2014-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
4,700 |
|
- |
|
Schuermann James |
SVP, Sales & Marketing |
|
2014-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,600 |
8,579 |
|
- |
|
776 Records found
|
|
Page 9 of 32 |
|
|